Arcutis Biotherapeutics, Inc. (ARQT)
24.79
-0.29
(-1.16%)
USD |
NASDAQ |
Aug 24, 16:00
24.79
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Market Cap : 3.113B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 3.150B |
| August 20, 2026 | 3.184B |
| August 19, 2026 | 3.323B |
| August 18, 2026 | 3.333B |
| August 17, 2026 | 3.216B |
| August 14, 2026 | 3.289B |
| August 13, 2026 | 3.244B |
| August 12, 2026 | 3.301B |
| August 11, 2026 | 3.294B |
| August 10, 2026 | 3.255B |
| August 07, 2026 | 3.176B |
| August 06, 2026 | 3.319B |
| August 05, 2026 | 3.404B |
| August 04, 2026 | 3.269B |
| August 03, 2026 | 3.258B |
| July 31, 2026 | 3.359B |
| July 30, 2026 | 3.500B |
| July 29, 2026 | 3.484B |
| July 28, 2026 | 3.554B |
| July 27, 2026 | 3.481B |
| July 24, 2026 | 3.420B |
| July 23, 2026 | 3.417B |
| July 22, 2026 | 3.489B |
| July 21, 2026 | 3.534B |
| July 20, 2026 | 3.442B |
| Date | Value |
|---|---|
| July 17, 2026 | 3.562B |
| July 16, 2026 | 3.469B |
| July 15, 2026 | 3.474B |
| July 14, 2026 | 3.352B |
| July 13, 2026 | 3.391B |
| July 10, 2026 | 3.469B |
| July 09, 2026 | 3.599B |
| July 08, 2026 | 3.564B |
| July 07, 2026 | 3.460B |
| July 06, 2026 | 3.260B |
| July 02, 2026 | 3.227B |
| July 01, 2026 | 3.231B |
| June 30, 2026 | 3.279B |
| June 29, 2026 | 3.346B |
| June 26, 2026 | 3.376B |
| June 25, 2026 | 3.337B |
| June 24, 2026 | 3.422B |
| June 23, 2026 | 3.285B |
| June 22, 2026 | 3.334B |
| June 18, 2026 | 3.277B |
| June 17, 2026 | 3.279B |
| June 16, 2026 | 3.210B |
| June 15, 2026 | 3.199B |
| June 12, 2026 | 3.049B |
| June 11, 2026 | 3.075B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 5.100B |
| Insmed, Inc. | 27.07B |
| Emergent BioSolutions, Inc. | 265.22M |
| Exelixis, Inc. | 13.58B |
| Vertex Pharmaceuticals, Inc. | 138.77B |
Market Cap Related Metrics
| PE Ratio | 119.70 |
| PS Ratio | 7.130 |
| Price to Book Value | 14.11 |
| Price to Free Cash Flow | 84.50 |
| Price | 24.79 |
| Earnings Yield | 0.84% |
| Operating PE Ratio | 96.58 |
| Normalized PE Ratio | 119.47 |